5MM-45722-30362
4 vaccinations
11 coded responses
50 check-ins
10 free-text entries
9 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 191 / PA
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
-
2021-01-31
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Survey response — day 0, dose 2MedDRA: Adverse reaction — Feeling: Good · Site: Pain, SwellingFree text: Approx 16 days after my first dose I experienced what may have been a small MR negative stroke (docs are still working up my case/have not arrived at a final dx). Im assuming it is entirely unrelated and was cleared by my doctors to receive the 2nd dose, but just reporting on the off chance that it has happened to others as well.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Loss of consciousness, Presyncope — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Loss of consciousness/vasovagal episodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-14
-
2021-02-21
Survey response — day 21, dose 2MedDRA: Cognitive disorder, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: -increasingly noticing cognitive changes/difficulties, perhaps related to the potential MR-negative stroke I had ~2.5 weeks post first dose. Have spoken with my PCP, and have an upcoming visit with neurologyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-28
-
2021-03-07
Survey response — day 35, dose 2MedDRA: Cognitive disorder, Facial paralysis, Hypoaesthesia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: #NAME?MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-14
- 2021-05-04
-
2021-06-03
Call successfulCompleted over the phone
-
2021-08-01
Survey response — 6 months, dose 2MedDRA: Inflammation, Office visit, Unevaluable event, Visual evoked potentials abnormal — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: More symptoms in line with potential neuroinflammatory syndrome/condition. Possible autoimmune culprit. Still being followed by neurology. March 2021 MRI still clear, abnormal VEP late June 2021 (bilaterally prolonged latencies) · Healthcare visit (other): Outpatient evoked potential imagingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-01
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
- 2021-08-10
-
2021-08-20
Dose 3 — Pfizer-BioNTech
-
2021-08-21
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-27
- 2021-09-03
- 2021-09-10
- 2021-09-19
-
2021-09-24
Survey response — day 35, dose 3MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worsening numbness/tingling in areas of my body.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-09-29
-
2021-10-02
Survey response — day 42, dose 3MedDRA: Sensory disturbance, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Continued sensory abnormalities -- a bit increased in frequency and location. · Healthcare visit (other): MRI of head, cervical + thoracic spineMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-05
Call successfulParticipant prefers to complete VAERS report online
-
2022-02-17
Dose 4 — Pfizer-BioNTech
-
2022-02-18
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-02-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-02-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2022-02-22
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2022-02-23
- 2022-02-24
-
2022-03-03
Survey response — day 14, dose 4MedDRA: Arthralgia, Headache, Neck pain — Feeling: GoodFree text: Headaches periodically bursts of very intense pain on left side of head Neck and shoulder pain on left sideMedDRA releases: 2024-11 · check-in free text available
- 2022-03-10
- 2022-03-17
-
2022-03-24
Survey response — day 35, dose 4MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-03-31
-
2022-05-19
Survey response — 3 months, dose 4MedDRA: Fatigue, Pain, Productive cough, Pyrexia, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: fever, productive cough, runny nose, body aches, fatigue (3x rapid antigen tests for COVID-19 negative, no PCR test done, not tested for flu or any other illnesses)MedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-20
- 2022-05-20
- 2022-05-20
- 2022-05-20
- 2022-05-20
- 2022-05-20
- 2022-05-20
-
2023-02-19
Survey response — 12 months, dose 4MedDRA: COVID-19, Malaise, Respiratory tract infection, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-02-19
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-02-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-01-31 | Pfizer-BioNTech | |
| 3 | 2021-08-20 | Pfizer-BioNTech | No |
| 4 | 2022-02-17 | Pfizer-BioNTech | No |
Call center
9 call center cases
8 successful · 1 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 3
4 waits over 3 months for a first call
Free text
Release 3 — day 0, dose 2
Systemic reaction (other): Approx 16 days after my first dose I experienced what may have been a small MR negative stroke (docs are still working up my case/have not arrived at a final dx). Im assuming it is entirely unrelated and was cleared by my doctors to receive the 2nd dose, but just reporting on the off chance that it has happened to others as well.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of consciousness/vasovagal episode
Release 4 — day 21, dose 2
Symptoms: -increasingly noticing cognitive changes/difficulties, perhaps related to the potential MR-negative stroke I had ~2.5 weeks post first dose. Have spoken with my PCP, and have an upcoming visit with neurology
Release 5 — day 35, dose 2
Symptoms: #NAME?
Release 9 — 6 months, dose 2
Symptoms: More symptoms in line with potential neuroinflammatory syndrome/condition. Possible autoimmune culprit. Still being followed by neurology. March 2021 MRI still clear, abnormal VEP late June 2021 (bilaterally prolonged latencies)
Healthcare visit (other): Outpatient evoked potential imaging
Release 9 — day 35, dose 3
Symptoms: Worsening numbness/tingling in areas of my body.
Release 9 — day 42, dose 3
Symptoms: Continued sensory abnormalities -- a bit increased in frequency and location.
Healthcare visit (other): MRI of head, cervical + thoracic spine
Release 11 — day 14, dose 4
Symptoms: Headaches periodically bursts of very intense pain on left side of head Neck and shoulder pain on left side
Release 11 — day 35, dose 4
Symptoms: Headache
Release 11 — 3 months, dose 4
Symptoms: fever, productive cough, runny nose, body aches, fatigue (3x rapid antigen tests for COVID-19 negative, no PCR test done, not tested for flu or any other illnesses)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Cognitive disorder | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Facial paralysis | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Inflammation | ✓ | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Medical counselling | ✓ | ✓ | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Office visit | ✓ | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sensory disturbance | · | · | ✓ |
| SD | Visual evoked potentials abnormal | ✓ | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Loss of consciousness | ✓ | ✓ | ✓ |
| SRO | Presyncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release